BioSpace News Archive

Drug Development

Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults

Neurocrine Biosciences, Inc. (Nasdaq: NBIX), today announced the initiation of its Phase 1 first-in-human clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational compound NBI-1117567 in healthy adult participants.

May 8, 2024
·
4 min read
Business

Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast

Moleculin Biotech, Inc. today announced that it will report its financial results for the quarter ended March 31, 2024, on Friday, May 10, 2024.

May 8, 2024
·
2 min read
BioMidwest

Neogen® to Participate in the Bank of America 2024 Health Care Conference

Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the Bank of America 2024 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 15, 2024.

May 8, 2024
·
1 min read
Pharm Country

Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024

Coeptis Therapeutics Holdings, Inc. announced today that the Company has been selected for an oral presentation of the abstract titled Developing A First-In-Class Universal Allogeneic Snap-Car NK Cell Therapy at the International Society for Cell & Gene Therapy 2024, being held May 28th to June 1st in Vancouver, Canada.

May 8, 2024
·
6 min read
Biotech Bay

Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines

Anixa Biosciences, Inc., a clinical-stage biotechnology company focused on the treatment and prevention of cancer, announced that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types.

May 8, 2024
·
5 min read
Brain Cancer Canada awards The Dwayne Andrews Glioblastoma Grant for Research to a study on the impact of anesthetics on brain cancer proliferation

Brain Cancer Canada is excited to announce the issuance of an $80,000 grant to support groundbreaking research by Dr. Sujoy Banik and his team at Lawson Health Research Institute in London, Ontario, Canada.

May 8, 2024
·
2 min read
Business

Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024

Xtant Medical Holdings, Inc. today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024.

May 8, 2024
·
1 min read
Business

Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended March 31, 2024 and provided a business update.

May 8, 2024
·
13 min read
Biotech Beach

Halozyme to Participate in Upcoming Investor Conferences - May 8, 2024

Halozyme Therapeutics, Inc. today announced that Nicole LaBrosse, Chief Financial Officer, is scheduled to present and host investor meetings at the following investor conferences.

May 8, 2024
·
2 min read
Business

AdvanCell Expands Leadership Team with the Appointment of Christopher Horvath, MS MBA, as Chief Commercial Officer & Chief Operating Officer and Gary Li, PhD, as Chief Strategy Officer

AdvanCell today announced the appointment of two senior management team members.

May 8, 2024
·
3 min read